1. Home
  2. VSTM vs WIMI Comparison

VSTM vs WIMI Comparison

Compare VSTM & WIMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSTM
  • WIMI
  • Stock Information
  • Founded
  • VSTM 2010
  • WIMI 2015
  • Country
  • VSTM United States
  • WIMI China
  • Employees
  • VSTM N/A
  • WIMI N/A
  • Industry
  • VSTM Biotechnology: Pharmaceutical Preparations
  • WIMI Computer Software: Prepackaged Software
  • Sector
  • VSTM Health Care
  • WIMI Technology
  • Exchange
  • VSTM Nasdaq
  • WIMI Nasdaq
  • Market Cap
  • VSTM 132.0M
  • WIMI 97.0M
  • IPO Year
  • VSTM 2012
  • WIMI 2020
  • Fundamental
  • Price
  • VSTM $3.88
  • WIMI $0.88
  • Analyst Decision
  • VSTM Strong Buy
  • WIMI
  • Analyst Count
  • VSTM 8
  • WIMI 0
  • Target Price
  • VSTM $14.57
  • WIMI N/A
  • AVG Volume (30 Days)
  • VSTM 1.1M
  • WIMI 408.8K
  • Earning Date
  • VSTM 11-06-2024
  • WIMI 01-01-0001
  • Dividend Yield
  • VSTM N/A
  • WIMI N/A
  • EPS Growth
  • VSTM N/A
  • WIMI N/A
  • EPS
  • VSTM N/A
  • WIMI N/A
  • Revenue
  • VSTM $10,000,000.00
  • WIMI $84,137,968.00
  • Revenue This Year
  • VSTM N/A
  • WIMI N/A
  • Revenue Next Year
  • VSTM $125.69
  • WIMI N/A
  • P/E Ratio
  • VSTM N/A
  • WIMI N/A
  • Revenue Growth
  • VSTM N/A
  • WIMI 19.25
  • 52 Week Low
  • VSTM $2.10
  • WIMI $0.56
  • 52 Week High
  • VSTM $14.22
  • WIMI $1.87
  • Technical
  • Relative Strength Index (RSI)
  • VSTM 63.77
  • WIMI 47.40
  • Support Level
  • VSTM $3.11
  • WIMI $0.88
  • Resistance Level
  • VSTM $3.76
  • WIMI $0.90
  • Average True Range (ATR)
  • VSTM 0.33
  • WIMI 0.04
  • MACD
  • VSTM 0.04
  • WIMI -0.01
  • Stochastic Oscillator
  • VSTM 94.26
  • WIMI 26.76

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

About WIMI WiMi Hologram Cloud Inc.

WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings primarily consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.

Share on Social Networks: